About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Global Company News
Precision Over Potency: Personalised Cannabis Medicine is Coming of Age
One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how…
Read more
Herer Legacy Goes Global: Dan Herer and Somai Pharmaceuticals Bring the Jack Herer Standard to the World
Dan Herer, son of the legendary Jack Herer, partners with Somai Pharmaceuticals to take the Herer standard worldwide. Blending grassroots…
Read more
How To Trade Cannabis Flower Globally: A Story Of Capital
The global medical cannabis markets are growing faster than we could have predicted, and new countries are expected to come…
Read more
Michael Sassano Talks Global Cannabis Markets, Regulatory Challenges, and Somai’s Vision from Sydney to Lisbon
Michael Sassano, CEO of Somai Pharmaceuticals, discusses global cannabis expansion, navigating regulations, and the future of cannabis products. Discover how…
Read more
Jack Herer Enters Global Pharma Market Through Partnership with SOMAÍ
The Jack Herer Brand, an iconic U.S.-based cannabis company, has announced a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically…
Read more
SOMAÍ Partners with SHERBINSKIS and BOUTIQ
A New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia…
Read more
Ireland Could Make Great Cannabis Policy: Examining the Past to Look Forward
Access to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make…
Read more
Product Dumping, White Labels, and Conflicts of Interest Lead to Global Cannabis Price Catastrophe
2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online…
Read more
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that…
Read more
The Shift Toward Recognised Brands in Medical Cannabis
For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market…
Read more
Q4 2024: Global Medical Cannabis Continues To Soar
The global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is…
Read more
SOMAÍ Joins Forces with Dascoli to Advance Swiss Medical Cannabis Market
Expanding its global footprint, SOMAÍ continues its European growth with a Swiss market entry through a strategic partnership with Dascoli…
Read more
U.S.-style cannabis dispensaries are sweeping global medical markets
Medical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions. Consumer flower…
Read more
2025 Cannabis Predictions: The Global Medical Cannabis Explosion Continues
2025 is poised for a massive explosion in the global medical cannabis market. Many politicians and regulators have been grappling…
Read more
SOMAÍ Pharmaceuticals and PACCAN Join Forces to Transform Medicinal Cannabis in Asia and Beyond
SOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis…
Read more
SOMAÍ Pharmaceuticals Redefines Patients Experience with the Launch of Origins and Senses Lines
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and…
Read more
Portugal em Direto – Maior Empresa Da Europa Está Em Portugal
Portugal é o “epicentro do cultivo e produção de canábis”, revela CEO da SOMAÍ Pharmaceuticals
Com uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para…
Read more
Cannabis industry predictions 2025: Market trends
Although new states continue to implement medical and adult-use cannabis programs, sales have been declining in the early adopters of…
Read more